InvestorsHub Logo
Followers 0
Posts 718
Boards Moderated 0
Alias Born 12/08/2009

Re: UnderR8D post# 11146

Tuesday, 12/08/2009 7:05:47 PM

Tuesday, December 08, 2009 7:05:47 PM

Post# of 25790
This is a funny board. Seems like everyone is taking Paramax for granted as an actual product, but fears a reverse split and dilution.

R/S and dilution is the best way for a developmental biotech to get funding. The alternative is usually a loan at usurious rates.

I would welcome a 100:1 R/S to bring the pps to 30 cents. And increasing the authorized shares doesn't concern me either.

What concerns me is the suspicion that "ParaMax" is a figment of someone's imagination. If the company is on the verge of getting 510(k) clearance for a device, they must have submitted the application in August... so why no mention of ParaMax in the guidance that accompanied the last 10Q?